**The market consensus strongly favors a cumulative influenza-associated hospitalization rate of 85–90 per 100,000 population through Week 23, 2026 (ending around June 6–13), reflecting CDC FluSurv-NET surveillance data.** By late May (Week 21), the cumulative rate had reached 87.4, up only marginally from 86.3 in Week 18 and 84.5 in mid-April, as weekly rates fell to 0.1 per 100,000 amid widespread low seasonal activity. This season’s elevated burden—driven by co-circulating influenza A strains—pushed the total higher than most prior years by spring, yet new admissions have slowed sharply with the end of peak transmission. Forecasters project continued minimal additions through mid-June, keeping the final cumulative figure within the 85–90 band. Realistic challenges include late, unexpected case clusters that add enough hospitalizations to push the rate into the low 90s, or data revisions from reporting delays that alter the final tally. The 94.5% implied probability captures the current evidence of a tapering season without major surprises.
Ringkasan eksperimental yang dihasilkan AI dengan referensi data Polymarket. Ini bukan saran trading dan tidak berperan dalam bagaimana pasar ini diselesaikan. · DiperbaruiFlu Hospitalization Rate Week 23, 2026?
Flu Hospitalization Rate Week 23, 2026?
85–90 94.8%
90–95 4.4%
95–100 <1%
<80 <1%
BARU
BARU
Jun 19, 2026
<80
<1%
80–85
<1%
85–90
95%
90–95
4%
95–100
1%
100+
<1%
85–90 94.8%
90–95 4.4%
95–100 <1%
<80 <1%
BARU
BARU
Jun 19, 2026
<80
$397 Vol.
<1%
80–85
$397 Vol.
<1%
85–90
$3,036 Vol.
95%
90–95
$143 Vol.
4%
95–100
$245 Vol.
1%
100+
$455 Vol.
<1%
This market will resolve according to the cumulative influenza-associated hospitalization rate per 100,000 population for the United States, as reported for the specified week.
If the recorded data falls exactly between two brackets, this market will resolve to the higher bracket.
The resolution source for this market will be CDC FluView / FluSurv-NET (see: https://www.cdc.gov/fluview/index.html). If the FluSurv-NET hospitalization rate for the specified week is not released by 11:59 PM ET on the tenth calendar day following the date of the prior FluView weekly report release, this market will resolve to the lowest bracket.
Note: Only the CDC FluSurv-NET cumulative hospitalization rate per 100,000 population for the specified week will qualify, regardless of estimates, projections, state-level reports, or other influenza surveillance metrics published by the CDC or other sources.**The market consensus strongly favors a cumulative influenza-associated hospitalization rate of 85–90 per 100,000 population through Week 23, 2026 (ending around June 6–13), reflecting CDC FluSurv-NET surveillance data.**
By late May (Week 21), the cumulative rate had reached 87.4, up only marginally from 86.3 in Week 18 and 84.5 in mid-April, as weekly rates fell to 0.1 per 100,000 amid widespread low seasonal activity. This season’s elevated burden—driven by co-circulating influenza A strains—pushed the total higher than most prior years by spring, yet new admissions have slowed sharply with the end of peak transmission. Forecasters project continued minimal additions through mid-June, keeping the final cumulative figure within the 85–90 band.
Realistic challenges include late, unexpected case clusters that add enough hospitalizations to push the rate into the low 90s, or data revisions from reporting delays that alter the final tally. The 94.5% implied probability captures the current evidence of a tapering season without major surprises.
This market will resolve according to the cumulative influenza-associated hospitalization rate per 100,000 population for the United States, as reported for the specified week.
If the recorded data falls exactly between two brackets, this market will resolve to the higher bracket.
The resolution source for this market will be CDC FluView / FluSurv-NET (see: https://www.cdc.gov/fluview/index.html). If the FluSurv-NET hospitalization rate for the specified week is not released by 11:59 PM ET on the tenth calendar day following the date of the prior FluView weekly report release, this market will resolve to the lowest bracket.
Note: Only the CDC FluSurv-NET cumulative hospitalization rate per 100,000 population for the specified week will qualify, regardless of estimates, projections, state-level reports, or other influenza surveillance metrics published by the CDC or other sources.
If the recorded data falls exactly between two brackets, this market will resolve to the higher bracket.
The resolution source for this market will be CDC FluView / FluSurv-NET (see: https://www.cdc.gov/fluview/index.html). If the FluSurv-NET hospitalization rate for the specified week is not released by 11:59 PM ET on the tenth calendar day following the date of the prior FluView weekly report release, this market will resolve to the lowest bracket.
Note: Only the CDC FluSurv-NET cumulative hospitalization rate per 100,000 population for the specified week will qualify, regardless of estimates, projections, state-level reports, or other influenza surveillance metrics published by the CDC or other sources.
Pasar Dibuka: Jun 12, 2026, 7:22 PM ET
Volume
$4,674Tanggal Berakhir
Jun 19, 2026Pasar Dibuka
Jun 12, 2026, 7:22 PM ETResolver
0x69c47De9D...This market will resolve according to the cumulative influenza-associated hospitalization rate per 100,000 population for the United States, as reported for the specified week.
If the recorded data falls exactly between two brackets, this market will resolve to the higher bracket.
The resolution source for this market will be CDC FluView / FluSurv-NET (see: https://www.cdc.gov/fluview/index.html). If the FluSurv-NET hospitalization rate for the specified week is not released by 11:59 PM ET on the tenth calendar day following the date of the prior FluView weekly report release, this market will resolve to the lowest bracket.
Note: Only the CDC FluSurv-NET cumulative hospitalization rate per 100,000 population for the specified week will qualify, regardless of estimates, projections, state-level reports, or other influenza surveillance metrics published by the CDC or other sources.**The market consensus strongly favors a cumulative influenza-associated hospitalization rate of 85–90 per 100,000 population through Week 23, 2026 (ending around June 6–13), reflecting CDC FluSurv-NET surveillance data.**
By late May (Week 21), the cumulative rate had reached 87.4, up only marginally from 86.3 in Week 18 and 84.5 in mid-April, as weekly rates fell to 0.1 per 100,000 amid widespread low seasonal activity. This season’s elevated burden—driven by co-circulating influenza A strains—pushed the total higher than most prior years by spring, yet new admissions have slowed sharply with the end of peak transmission. Forecasters project continued minimal additions through mid-June, keeping the final cumulative figure within the 85–90 band.
Realistic challenges include late, unexpected case clusters that add enough hospitalizations to push the rate into the low 90s, or data revisions from reporting delays that alter the final tally. The 94.5% implied probability captures the current evidence of a tapering season without major surprises.
This market will resolve according to the cumulative influenza-associated hospitalization rate per 100,000 population for the United States, as reported for the specified week.
If the recorded data falls exactly between two brackets, this market will resolve to the higher bracket.
The resolution source for this market will be CDC FluView / FluSurv-NET (see: https://www.cdc.gov/fluview/index.html). If the FluSurv-NET hospitalization rate for the specified week is not released by 11:59 PM ET on the tenth calendar day following the date of the prior FluView weekly report release, this market will resolve to the lowest bracket.
Note: Only the CDC FluSurv-NET cumulative hospitalization rate per 100,000 population for the specified week will qualify, regardless of estimates, projections, state-level reports, or other influenza surveillance metrics published by the CDC or other sources.
If the recorded data falls exactly between two brackets, this market will resolve to the higher bracket.
The resolution source for this market will be CDC FluView / FluSurv-NET (see: https://www.cdc.gov/fluview/index.html). If the FluSurv-NET hospitalization rate for the specified week is not released by 11:59 PM ET on the tenth calendar day following the date of the prior FluView weekly report release, this market will resolve to the lowest bracket.
Note: Only the CDC FluSurv-NET cumulative hospitalization rate per 100,000 population for the specified week will qualify, regardless of estimates, projections, state-level reports, or other influenza surveillance metrics published by the CDC or other sources.
Volume
$4,674Tanggal Berakhir
Jun 19, 2026Pasar Dibuka
Jun 12, 2026, 7:22 PM ETResolver
0x69c47De9D...**The market consensus strongly favors a cumulative influenza-associated hospitalization rate of 85–90 per 100,000 population through Week 23, 2026 (ending around June 6–13), reflecting CDC FluSurv-NET surveillance data.** By late May (Week 21), the cumulative rate had reached 87.4, up only marginally from 86.3 in Week 18 and 84.5 in mid-April, as weekly rates fell to 0.1 per 100,000 amid widespread low seasonal activity. This season’s elevated burden—driven by co-circulating influenza A strains—pushed the total higher than most prior years by spring, yet new admissions have slowed sharply with the end of peak transmission. Forecasters project continued minimal additions through mid-June, keeping the final cumulative figure within the 85–90 band. Realistic challenges include late, unexpected case clusters that add enough hospitalizations to push the rate into the low 90s, or data revisions from reporting delays that alter the final tally. The 94.5% implied probability captures the current evidence of a tapering season without major surprises.
Ringkasan eksperimental yang dihasilkan AI dengan referensi data Polymarket. Ini bukan saran trading dan tidak berperan dalam bagaimana pasar ini diselesaikan. · Diperbarui
Hati-hati dengan link eksternal.
Hati-hati dengan link eksternal.
Pertanyaan yang Sering Diajukan